Novelix Pharmaceuticals Ltd

AGM Details

• AGM held on 30 September 2026 at 03:00 IST via VC/OAVM.
• Quorum present; 73 members attended via VC/OAVM.

Resolutions

• Adopt standalone financial statements for year ended 31 March 2026.
• Re-appoint Ms. Sridevi Belide by rotation as director.
• Appoint Gnana Prakash Gattu as Whole Time Director (Special Resolution).
• Voting results to be disseminated within 48 hours of meeting conclusion.

Novelix Pharmaceuticals Ltd: Trading Window closed from Oct 1, 2026 till 48 hours after the declaration of unaudited financial results for the quarter and half year ended Sep 30, 2026.

AGM notice & online access

• AGM: 32nd Annual General Meeting on 30 Sep 2026 at 3:00 PM IST via video conferencing.
• Annual Report 2025-26 and AGM Notice online at novelixpharma.com/annual-report/.
• Members without registered emails were sent a weblink and path to AR/Notice access.
• Please update email addresses to receive communications electronically; process outlined on company website.
• Physical shareholders: submit ISR form to RTA; Demat holders: contact DP for updates.
• RTA: Venture Capital and Corporate Investments Pvt. Ltd; contact details and email provided.

AGM details

• Date and time: 30 September 2026 at 03:00 PM
• Mode: VC/OAVM
• Record/book closure: 24–30 September 2026; cut-off date 23 September 2026

Ordinary business

• Adoption of standalone financial statements for year ended 31 March 2026
• Re-appointment of Ms. Sridevi Belide as director retiring by rotation

Special business

• Appointment of Gnana Prakash Gattu as Whole Time Director for 5 years

Director changes

• Ms. Sridevi Belide to be re-appointed as Non-Executive Director
• Mr. Gnana Prakash Gattu to be appointed Whole Time Director

Voting window

• Remote e-voting period: 27 Sept 2026 09:00 to 29 Sept 2026 17:00
• Voting rights cut-off: 23 Sept 2026

Financial highlights

• Revenue from operations: ₹13,230.62 Lakhs in FY2025-26.
• Total revenue: ₹13,233.88 Lakhs including other income.
• Profit after tax: ₹255.66 Lakhs; Basic EPS ₹1.21; Diluted ₹1.75.
• Dividend not declared for FY2025-26.
• Total equity: ₹4,648.84 Lakhs; total assets: ₹9,242.32 Lakhs.

Operations & segment focus

• Pharma revenue dominates: ₹13,230.62 Lakhs; other segments nil.
• No subsidiaries; focus on pharma bulk drugs and intermediates.
• Investments: ₹4.32 Lakhs in Matra Kaushal Enterprises.
• R&D and technology focus; Hyderabad ecosystem leveraged.
• MD&A notes compliance with SEBI LODR; disciplined growth.

Capital structure & equity

• Authorised capital ₹30 Crore; paid-up ₹21.09 Crore.
• Private placement: 2.32 million equity shares at ₹60.
• EPS denominators: basic 9.95m; diluted 9.17m shares.
• Post-year-end: 7.385 million equity shares allotted.

Balance sheet snapshot

• Total assets ₹9,242.32 Lakhs; current assets ₹8,891.12 Lakhs.
• Inventories ₹1,443.22 Lakhs; trade receivables ₹5,896.15.
• Cash & equivalents ₹295.86 Lakhs; current liabilities ₹4,593.48 Lakhs.
• Equity ₹4,648.84 Lakhs; no material non-current borrowings disclosed.

Governance & board changes

• Gnana Prakash Gattu appointed Whole-Time Director for five years from Aug 29, 2026.
• Board size six; three independent directors.
• Multiple board/committee meetings held in FY2025-26.

Audit & internal controls

• Statutory auditors CVS Balachandra Rao & Co; unqualified report.
• Inventory valuation identified as a key audit matter.
• Internal audit by VRPS & Co; audit trail gaps reported.
• Secretarial audit by Khushbu Kanwar & Co; unqualified.

Outlook & risks

• Outlook remains positive; focus on APIs, intermediates and Healthcare R&T.
• Regulatory compliance, raw materials, currency, and competition risks.
• Hyderabad ecosystem supports future growth; disciplined capital deployment.

Related party & compliance

• Related party transactions approved by Audit Committee; disclosed in notes.
• Directors' remuneration disclosed; year-end related party balances NIL.
• MSME payments compliant; no dues beyond 45 days.

AGM Details

• AGM on 30 September 2026 at 03:00 PM, held via Video Conferencing/OAVM.
• Register of Members and transfer books closed 24 Sep 2026 to 30 Sep 2026.
• Cut-off date for voting eligibility: 23 Sep 2026.
• Remote e-voting from 27 Sep 2026 09:00 to 29 Sep 2026 17:00.

Appointment of Whole Time Director

• Gnana Prakash Gattu appointed Whole Time Director for five years, effective 29 August 2026, with AGM approval.
• Date of appointment: 29 August 2026; term: five years subject to member approval at AGM.
• Reason: change in designation to Whole Time Director.
• Profile: IIT-Chennai graduate with 25+ years in management and information technology.
• Relation: not related to any director or KMP; belongs to Promoter group.
• Debarment: not debarred by SEBI or other authorities.

Key board decisions

• Board approved the Board Report and annexures for the financial year ended 31 March 2026.
• Draft AGM notice approved for 32nd AGM on 30 September 2026.
• AGM scheduled for 30 September 2026 at 03:00 PM via video conferencing/OAVM.
• Register of members and share transfer books to close 24–30 September 2026.
• Appointed M/s Bharat Khaniwal & Co. as Scrutinizer for remote and AGM voting.
• Voting cutoff date for AGM eligibility fixed as 23 September 2026.
• Gnana Prakash Gattu appointed as Whole-time Director effective 29 August 2026 for five years, subject to member approval.

Meeting Details

• Date: 29 August 2026; Time: not disclosed; Location: Registered office of the Company.

Key Agenda Items

• Approve Notice of 32nd AGM with date/time/venue.
• Approve Board Report and Annexures for FY ended 31 March 2026.
• Appoint Scrutinizer for AGM and remote e-voting.
• Approve appointment of Mr. Gnana Prakash Gattu as Whole-Time Director.

Other Notes

• No trading window details provided.